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Acute hemichorea can occur in the context of infectious, autoimmune, metabolic, toxic, 
and vascular neuropathologies. Primary infection by varicella zoster virus (VZV) can result in 
vasculopathy with neurological manifestations, such as hemiparesis, at times accompanied 
by hemichorea. Isolated hemichorea, however, had not been reported. We here describe two 
cases of VZV-induced vasculopathy whose sole clinical manifestation was acute hemichorea. 
Both cases involved young boys of 3 years of age, who presented with acute hemichorea 
4–6 months after initial VZV infection. All hematological, immunological, and toxicological 
tests were normal, except for the presence of VZV IgG. Brain structural magnetic resonance 
imaging (MRI) and magnetic resonance angiography revealed specific signs of vasculitis and 
ischemic lesions in the basal ganglia region (lentiform nucleus, thalamus, and internal capsule). 
Following corticosteroid and acetylsalicylic acid treatment, full symptomatic recovery was 
achieved within 3 weeks. Repeated MRI documented full neurostructural recovery, which was 
confirmed at extended follow-up for more than 1 year. These cases indicate that VZV-induced 
vasculopathy should be considered in the case of pediatric isolated acute hemichorea.
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BaCKGRoUND
Hemichorea is a rather uncommon clinical presentation that results from unilateral basal ganglia damage 
(1). Its etiopathogenesis can be diverse, including infectious, autoimmune, metabolic, toxic, and vascular 
mechanisms (2–6). In school-age children, hemichorea is often a manifestation of Sydenham’s chorea, 
even though bilateral chorea is the usual presentation (2). A well-known mechanism underlying choreic 
movements is vasculopathy leading to hemorrhagic or hypoxic–ischemic lesions of the basal ganglia (7).
The varicella zoster virus (VZV) is a highly contagious neurotropic alpha-herpes virus, whose 
primary infection results in a typical exanthematic disease (varicella) and can be complicated by 
vasculopathy. VZV-induced vasculopathy can lead to ischemic or hemorrhagic lesions, with pos-
sible clinical manifestations of stroke, transient ischemic attacks, and hemiparesis, with or without 
hemichorea (8, 9). It is estimated that VZV vasculopathy accounts for about one-third of all pediatric 
strokes, usually presenting as acute hemiparesis (7, 10–12). However, to the best of our knowledge, 
no case of acute hemichorea with MRI-documented evidence of basal ganglia and internal capsule 
ischemic lesions after VZV infection had been reported. We here describe two clinical cases of VZV 
vasculopathy in young children whose sole clinical sign was acute hemichorea.
Case 1
A 3-year and 8-month-old boy presented to the hospital emergency department for acute onset of 
involuntary movements of the right side of the body. Except for hemichorea, no other neurological 
FIGURe 1 | Case 1: (a) axial FLAIR image and (B) axial T2 weighted image, 
showing ischemic lesion involving the left lentiform nucleus and posterior limb 
of the internal capsule. (C) Axial FLAIR image and (D) axial T2 weighted 
image showing resolution of the left lentiform nucleus lesion and reduction of 
the posterior limb involvement in the internal capsule.
FIGURe 2 | Case 2: (a) axial T1 image and (B) axial T2 weighted image, 
showing right thalamic nucleus and posterior limb of the internal capsule 
ischemic lesions. (C) Axial T2 weighted image and (D) axial T1 weighted 
image showing resolution of the right thalamic nucleus lesion and reduction 
of the involvement of the posterior limb of the internal capsule.
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sign or symptom was detected. Six months before the acute 
onset of hemichorea, he had had varicella (chickenpox). He was 
previously healthy, with negative family history of movement 
disorders. Complete blood count, erythrocyte sedimentation rate 
(ESR), C reactive protein (CRP), hemoglobin S, kidney, liver and 
thyroid function, anti-DNAse B antibodies, total immunoglobu-
lines, lupus anticoagulant, antinuclear antibodies, anticardiolipin 
antibodies, anti-B2 glycoprotein antibodies, and coagulation tests 
were normal. Toxicological screening and metabolic panel were 
negative. Pharyngeal swab was normal, as well as electrocardio-
gram (ECG) and electroencephalogram (EEG). Serum anti-VZV 
IgGs were positive. Brain MRI (Figures 1A,B) revealed ischemic 
lesions involving the left lentiform nucleus and the posterior limb 
of internal capsule.
Following treatment with acetylsalicylic acid (2 mg/kg/day), 
prednisone (0.9 mg/kg/day), and haloperidol (0.03 mg/kg/day), 
there was a complete resolution of the hemichorea by 3 weeks 
after the acute onset. Four months later, brain MRI showed 
resolution of the lesion in the left lentiform nucleus and a reduc-
tion of the lesion in the posterior limb of the internal capsule 
(Figures 1C,D). An extended follow-up for 16 months confirmed 
the complete clinical recovery.
Case 2
A 3-year and 5-month-old boy was brought to the hospital 
emergency department with left side hemichorea that had 
suddenly appeared about 2 days earlier. No other neurological 
sign was detected. Medical history was significant for varicella 
4 months before the admission. Family history was negative for 
movement disorders. Laboratory investigations, including blood 
count, ESR, CRP, hemoglobin S, kidney, liver and thyroid func-
tion, anti-DNAse B antibodies, total immunoglobulines, lupus 
anticoagulant, antinuclear antibodies, anticardiolipin antibod-
ies, anti-B2 glycoprotein antibodies, and extensive coagulation 
tests, were all normal. Serum VSZ IgGs were positive. Metabolic 
panel, EEG, ECG, and echocardiogram were normal. Brain MRI 
revealed ischemic lesions in the right thalamic nucleus and the 
posterior limb of internal capsule (Figures  2A,B). Magnetic 
resonance angiography (MRA) showed a reduced caliber of right 
internal carotid artery, especially evident in the supra-clinoid 
segment, and of the M1 segment of the middle cerebral artery, 
hypoplasia of the right A1 segment anterior cerebral artery and 
tortuosity of the vertebrobasilar system (Figure 3).
Treatment with acetylsalicylic acid (2  mg/kg/day), pred-
nisone (0.4 mg/kg/day), and haloperidol (0.03 mg/kg/day) was 
initiated. The hemichorea immediately improved, and the boy 
recovered completely in 3  weeks. Five months later, a brain 
MRI (Figures  2C,D) showed resolution of the lesion in the 
right thalamic nucleus and a reduction of the posterior limb of 
internal capsule involvement. This picture was consistent with a 
post-VZV vasculitis causing an asymptomatic ischemic lacunar 
lesion, and a transient hypoperfusion leading to hemichorea. 
An extended follow-up for 28 months confirmed the complete 
clinical recovery.
FIGURe 3 | Case 2: Magnetic resonance angiography (MRA) showing 
reduced caliber of the right internal carotid artery, especially the supra-clinoid 
segment, and of the M1 segment of the middle cerebral artery, hypoplasia of 
the right A1 segment of the anterior cerebral artery, and tortuosity of the 
vertebrobasilar system.
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DIsCUssIoN
Acute hemichorea is due to a contralateral damage of the basal 
ganglia. The etiopathogenesis can involve infectious, autoim-
mune, vascular, metabolic, or toxic mechanisms, leading to acute 
injury of the putamen and/or caudate nucleus (1, 13). The most 
common cause in children is rheumatic fever, an autoimmune 
reaction triggered by group A beta-hemolytic Streptococcus infec-
tion that can manifest with abnormal, involuntary movements 
(Sydenham’s chorea). The typical neurological manifestation 
of rheumatic fever, however, is bilateral chorea, rather than 
hemichorea (2). The age of onset of Sydenham’s chorea is usually 
8–9 years. In children, hemichorea can also be one of the signs 
of Rasmussen’s encephalitis, a rare and progressive autoimmune 
unilateral inflammation of the brain that results in seizures and 
hemiparesis (13).
Chorea and, less frequently, hemichorea have been reported 
also in the context of viral infections. VZV, herpes simplex, and 
influenza A viruses can cause encephalitis with various move-
ment disorders, including also chorea (4, 14, 15). HIV infection 
can set the stage for opportunistic infections, such as histoplas-
mosis, with central nervous system involvement and consequent 
hemichorea (16).
To the best of our knowledge, this is the first report of acute-
onset hemichorea as the sole neurological sign of a recent VZV 
infection. These otherwise healthy 3-year-old children suddenly 
developed hemichorea 4 and 6  months, respectively, after the 
primary VZV infection. Other possible etiological explanations 
were excluded, including Sydenham’s chorea, which is rare 
under 5 years of age (17). Extensive hematological, endocrine, 
autoimmune, and ECG and EEG assessments were conducted. 
CSF was not obtained because it was not clinically indicated. It 
should be noted that testing for VZV IgG in the CSF may not 
exclude a diagnosis of VZV-induced vasculopathy because of the 
low sensitivity in children (18). The time interval of 4–6 months, 
from the primary infection until the appearance of hemichorea, 
is consistent with previous reports of VZV vasculopathy (19). 
Finally, repeated MRI examinations documented vasculopathic 
lesions of the basal ganglia area, which resolved in the follow-
ing weeks together with the hemichorea. It has been previously 
documented that the typical brain MRI signs of VZV vasculopa-
thy are ischemic lesions of the basal ganglia and/or the internal 
capsule (19).
The most common complications of varicella are bacterial 
infections of the skin and soft tissues in children and pneumonia 
in adults. Less frequent are viral pneumonia, septicemia, toxic 
shock, necrotizing fasciitis, osteomyelitis, septic arthritis, and 
neurological complications. The neurotropism of VZV is well 
known. After the primary infection, VZV usually establishes in 
the neurons of the cranial nerves, dorsal roots, and autonomic 
ganglia, as well as the adrenal glands, remaining latent for many 
years before reactivating in debilitated and immunocompro-
mised individuals to cause herpes zoster (shingles). Neurological 
involvement can appear also during the primary VZV infection 
or in the following 4–6 months (but cases as early as 1 week and 
as long as 48 months have been reported). In children, rates of 
post-VZV neurological complications ranging from 3.9 to 61.3% 
have been reported (4, 20, 21). Severe neurological complications, 
however, are rare in immunocompetent children (4). Central 
nervous system involvement may cause encephalitis, meningitis, 
cerebellitis, acute myelitis, and vasculopathy, with various possi-
ble clinical manifestations, such as stroke or stroke-like episodes, 
ataxia, seizures, acute headache, cranial nerve palsy, syncope, 
tremors, and drowsiness.
VZV-induced angiopathy is much more common after the 
initial infection than with herpes zoster. It can involve different 
kind of vessels: central or peripheral, and arteries or veins of dif-
ferent caliber. For example, deep venous thrombosis can lead to 
pulmonary embolism or purpura fulminans, as well as arterial 
complications, such as giant cells arteritis affecting extracranial 
circulation or granulomatous aortitis (19, 22). VZV can affect 
intracerebral arteries, producing changes in arterial caliber and 
contractility and leading to stroke. The underlying pathogenesis 
of VZV vasculopathy is probably mediated by accumulation of 
inflammatory cells in the media layer of the cerebral arteries, with 
progressive thickening of the vessel wall and dysfunction in nitric 
oxide metabolism (19).
The prognosis of the neurological complications of VZV 
vasculopathy is usually good, with complete functional recovery, 
even without specific pharmacological treatment (7). However, 
residual symptoms, such as dystonia, have been reported at a 
rate as high as 12% (10, 23). The efficacy of treatment in VZV 
vasculopathy is controversial, and there is debate about the 
benefit of antiviral and anti-inflammatory therapy. Acyclovir is 
recommended in cases in which VZV is isolated in the CSF (24). 
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Both salicylates and corticosteroids have been used in an attempt 
to ameliorate the inflammatory processes, and antidopaminergic 
agents, such as haloperidol, can help control the movement 
disorder when this is distressing or invalidating. However, the 
efficacy of these treatments for accelerating or achieving recovery 
is unclear.
In conclusion, these two cases provide evidence that acute 
hemichorea can be the only clinical manifestation of post-VZV 
vasculopathy. VZV vasculopathy should be considered among 
the possible causes of acute-onset hemichorea, especially in 
children younger than 5 years, even in the absence of hemiparesis.
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